Anlotinib Plus Docetaxel for the Treatment of EGFR Wild-type Advanced Non-small-cell Lung Cancer
Clinical trial NCT03624309 · UNKNOWN
Trial details
- NCT number
- NCT03624309
- Sponsor
- Hunan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-15
- Primary completion
- 2020-06-30
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.